Health Sputnik V Major UpdatesNovember 12, 2020ByCedar Point Chemist Ltd0Comments The first interim data analysis of the Sputnik V vaccine against COVID-19 phase III clinical trials in the Russian Federation demonstrated 92% efficacyRead more
